XBI News and Press, SPDR Series Trust S&P Biotech

2024-07-17 16:33:49 ET Summary The healthcare sector is traditionally defensive during economic downturns, but not all industries within the healthcare sector are created equal. abrdn Healthcare Investors Fund focuses on the more cyclical biotech space, with over half of its portf...

2024-07-17 04:42:00 ET Summary As medical companies leverage the power of artificial intelligence, genomics, and other groundbreaking discoveries, the boundaries between technology and healthcare continue to blur, presenting potential opportunities for both patients and investors. ...

2024-07-15 08:55:00 ET Summary The S&P 500 notched its 37th record high on Wednesday of last week. The best-performing groups last week were the small caps. The Goldilocks scenario would be a continuation of the broadening out to include small and mid-caps, while still kee...

2024-07-12 09:20:00 ET Summary We remain constructive on equities based on three general observations - investors’ renewed focus on corporate earnings, the gradual broadening of the stock market and the continuing global industrial rebound. In the near future, we expect fur...

2024-07-10 18:18:44 ET More on Tesla Wall Street Lunch: Tesla's Big Bull Run Surging Stock, Struggling Core: Tesla's Mixed Signals To Investors Tesla Stock: Sell The Rip Electric stuff: Tesla's business that may have more promise than autos, robots, or FSD ...

2024-07-09 07:00:00 ET Summary Biotech indexes lagged broader market indexes in the first half of 2024, and trade at the same level as in early 2022. Biotech valuations are closely tied to the Fed's interest rate policy and are highly correlated to the 10-year yield. Inflation...

2024-07-08 11:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-07-04 11:30:00 ET Summary This article will present an in-depth analysis of drugs being developed to combat obesity and related diseases. Pharmaceutical companies are highly interested in the global obesity treatment market, which is expected to exceed $100 billion by 2030. ...

2024-07-03 22:30:00 ET Summary Closing out the first half of 2024, the S&P 500 Total Return Index (which includes dividend reinvestment) is up an incredible +15.3%. According to Apollo asset management, Nvidia accounted for a record-breaking 34.5% of the total return in the S&...

2024-07-03 09:41:00 ET Summary Global stocks posted healthy gains in the first half of 2024, although second quarter performance moderated from the previous quarter’s breakneck pace. In a trend that has become familiar to equity investors, large-cap market breadth was again...